Physician

Andrew David Berke, M.D.

According to 2025 Medicare claims, Andrew Berke, M.D. (NPI: 1588738140) practices interventional cardiology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is CHS PHYSICIAN PARTNERS, P.C (NPI: 1164585725; TIN: 113613997) and primary practice location at 11576-1347. Berke is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Berke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 825 traditional Medicare patients, billed 3,496 HCPCS/CPT codes, and received $335,968 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,378 prescription claims across 167 beneficiaries totaling $269,292 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 54 records totaling $16,002. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	510	3,192	$458,225
2016	565	3,242	$491,361
2017	512	2,731	$417,559
2018	638	3,153	$371,312
2019	1,029	4,276	$409,092
2020	919	3,577	$367,401
2021	1,052	4,338	$429,707
2022	1,068	4,508	$415,902
2023	904	3,610	$356,616
2024	825	3,496	$335,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	173	1,746	$210,399
2016	151	1,494	$204,882
2017	170	1,419	$218,263
2018	168	1,383	$191,860
2019	170	1,400	$197,409
2020	165	1,314	$230,330
2021	167	1,360	$242,065
2022	165	1,356	$289,364
2023	156	1,113	$249,808
2024	167	1,378	$269,292

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	75	87	$155
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	168	405	$76
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	546	1,723	$72
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	231	483	$13
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	79	89	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	48	4,195	$74,130
Multaq	Dronedarone Hcl	24	1,680	$40,735
Eliquis	Apixaban	22	1,290	$24,123
Entresto	Sacubitril/Valsartan	16	1,440	$23,977
Repatha Sureclick	Evolocumab	41	1,212	$23,539

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$3,390	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$12,612	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew David Berke, M.D.?

Tedicare shows public-source Medicare data for Andrew David Berke, M.D. (NPI 1588738140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew David Berke, M.D. have ACO affiliation data?

Andrew David Berke, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Andrew David Berke, M.D.?

Andrew David Berke, M.D. is linked to CHS PHYSICIAN PARTNERS, P.C (billing NPI 1164585725) in the available physician profile data.

Does Andrew David Berke, M.D. have Open Payments data?

Andrew David Berke, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.